- Home
- VTYX vs CBNA Comparison
VTYX vs CBNA Comparison
Compare VTYX & CBNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- CBNA
- Stock Information
- Founded
- VTYX 2018
- CBNA 2006
- Country
- VTYX United States
- CBNA United States
- Employees
- VTYX N/A
- CBNA N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- CBNA
- Sector
- VTYX Health Care
- CBNA
- Exchange
- VTYX Nasdaq
- CBNA NYSE
- Market Cap
- VTYX 148.4M
- CBNA 133.2M
- IPO Year
- VTYX 2021
- CBNA 2024
- Fundamental
- Price
- VTYX $1.73
- CBNA $23.97
- Analyst Decision
- VTYX Buy
- CBNA Buy
- Analyst Count
- VTYX 5
- CBNA 3
- Target Price
- VTYX $8.40
- CBNA $27.67
- AVG Volume (30 Days)
- VTYX 1.1M
- CBNA 44.2K
- Earning Date
- VTYX 11-07-2024
- CBNA 10-29-2024
- Dividend Yield
- VTYX N/A
- CBNA N/A
- EPS Growth
- VTYX N/A
- CBNA N/A
- EPS
- VTYX N/A
- CBNA 749.51
- Revenue
- VTYX N/A
- CBNA $49,968,000.00
- Revenue This Year
- VTYX N/A
- CBNA N/A
- Revenue Next Year
- VTYX N/A
- CBNA N/A
- P/E Ratio
- VTYX N/A
- CBNA $0.03
- Revenue Growth
- VTYX N/A
- CBNA 76.01
- 52 Week Low
- VTYX $1.67
- CBNA $20.10
- 52 Week High
- VTYX $11.48
- CBNA $25.00
- Technical
- Relative Strength Index (RSI)
- VTYX 30.10
- CBNA N/A
- Support Level
- VTYX $2.10
- CBNA N/A
- Resistance Level
- VTYX $2.36
- CBNA N/A
- Average True Range (ATR)
- VTYX 0.12
- CBNA 0.00
- MACD
- VTYX -0.05
- CBNA 0.00
- Stochastic Oscillator
- VTYX 8.76
- CBNA 0.00
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About CBNA CHAIN BRIDGE BANCORP INC
Chain Bridge Bancorp Inc is engaged in banking industry. It offers commercial and personal banking services, including deposits, treasury management, payments, loans, commercial lending, residential mortgage financing, consumer loans, trusts and estate administration, wealth management, and asset custody.